Ceacam6 gene variants in inflammatory bowel disease

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Glas, Jürgen ^a,b,c   Seiderer, Julia ^a   Fries, Christoph ^a,b   Tillack, Cornelia ^a   Pfennig, Simone ^a   Weidinger, Maria ^a   Beigel, Florian ^a   Olszak, Torsten ^a,d   Lass, Ulrich ^e   Göke, Burkhard ^a   Ochsenkühn, Thomas ^a   Wolf, Christiane ^f   Lohse, Peter ^b   Müller Myhsok, Bertram ^f   Diegelmann, Julia ^a,b   Czamara, Darina ^f   Brand, Stephan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e TIB MOLBIOL GmbH   (Germany)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CELL PROTEIN; GENOMIC DNA; INTERLEUKIN 23 RECEPTOR; PROTEIN ATG16L1; UNCLASSIFIED DRUG; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; DNA; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ADHERENCE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6 GENE; CHILD; COLON CROHN DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; ENTERITIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; CASE CONTROL STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BACTERIAL ADHESION; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHILD; CROHN DISEASE; DNA; ESCHERICHIA COLI; FEMALE; GENETIC VARIATION; GPI-LINKED PROTEINS; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA;

EID: 79955750033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019319     Document Type: Article

References (56)

1. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Podolsky DK, (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429.
3. Mudter J, Neurath MF, (2007) Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications. Gut 56: 293-303.
4. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39: 830-832.
5. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-211.
6. Cooney R, Baker J, Brain O, Danis B, Pichulik T, et al. (2010) NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 16: 90-97.
7. Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, et al. (2010) Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 11: 55-62.
8. Sydora BC, Macfarlane SM, Walker JW, Dmytrash AL, Churchill TA, et al. (2007) Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse. Inflamm Bowel Dis 13: 947-954.
9. Silva MA, (2009) Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease. Inflamm Bowel Dis 15: 436-453.
10. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
11. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
12. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
13. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A, (2008) Pathogenic agents in inflammatory bowel diseases. Curr Opin Gastroenterol 24: 440-447.
14. Sokol H, Lay C, Seksik P, Tannock GW, (2008) Analysis of bacterial bowel communities of IBD patients: what has it revealed? Inflamm Bowel Dis 14: 858-867.
15. Cario E, Podolsky DK, (2006) Toll-like receptor signaling and its relevance to intestinal inflammation. Ann N Y Acad Sci 1072: 332-338.
16. Rhodes JM, (2007) The role of Escherichia coli in inflammatory bowel disease. Gut 56: 610-612.
17. Rolhion N, Darfeuille-Michaud A, (2007) Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 13: 1277-1283.
18. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, et al. (2009) Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 206: 2179-2189.
19. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, et al. (2007) CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 117: 1566-1574.
20. Khan WN, Frangsmyr L, Teglund S, Israelsson A, Bremer K, et al. (1992) Identification of three new genes and estimation of the size of the carcinoembryonic antigen family. Genomics 14: 384-390.
21. Obrink B, (1997) CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol 9: 616-626.
22. Kuespert K, Pils S, Hauck CR, (2006) CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 18: 565-571.
23. Thom I, Schult-Kronefeld O, Burkholder I, Schuch G, Andritzky B, et al. (2009) Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. Anticancer Res 29: 249-254.
24. Greicius G, Severinson E, Beauchemin N, Obrink B, Singer BB, (2003) CEACAM1 is a potent regulator of B cell receptor complex-induced activation. J Leukoc Biol 74: 126-134.
25. Muenzner P, Rohde M, Kneitz S, Hauck CR, (2005) CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells. J Cell Biol 170: 825-836.
26. Nagaishi T, Iijima H, Nakajima A, Chen D, Blumberg RS, (2006) Role of CEACAM1 as a regulator of T cells. Ann N Y Acad Sci 1072: 155-175.
27. Dango S, Sienel W, Schreiber M, Stremmel C, Kirschbaum A, et al. (2008) Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Lung Cancer 60: 426-433.
28. Nagaishi T, Pao L, Lin SH, Iijima H, Kaser A, et al. (2006) SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25: 769-781.
29. Gray-Owen SD, Blumberg RS, (2006) CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 6: 433-446.
30. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A, (1999) Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 67: 4499-4509.
31. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, et al. (2001) Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 69: 5529-5537.
32. Lennard-Jones JE, (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170: 2-6; discussion 16-19.
33. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, et al. (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 (Suppl A): 5-36.
34. Glas J, Seiderer J, Wetzke M, Konrad A, Torok HP, et al. (2007) rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS ONE 2: e819.
35. Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, et al. (2009) Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 104: 1737-1744.
36. Glas J, Seiderer J, Pasciuto G, Tillack C, Diegelmann J, et al. (2009) rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population. Am J Gastroenterol 104: 665-672.
37. Seiderer J, Schnitzler F, Brand S, Staudinger T, Pfennig S, et al. (2006) Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand J Gastroenterol 41: 1421-1432.
38. Callaghan MJ, Rockett K, Banner C, Haralambous E, Betts H, et al. (2008) Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease. Genes Immun 9: 30-37.
39. Roda G, Dahan S, Mezzanotte L, Caponi A, Roth-Walter F, et al. (2009) Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9. Inflamm Bowel Dis 15: 1775-1783.
40. Bastide P, Darido C, Pannequin J, Kist R, Robine S, et al. (2007) Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 178: 635-648.
41. Mori-Akiyama Y, van den Born M, van Es JH, Hamilton SR, Adams HP, et al. (2007) SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 133: 539-546.
42. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102: 18129-18134.
43. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53: 1658-1664.
44. Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, et al. (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57: 903-910.
45. Kaser A, Lee AH, Franke A, Glickman JN, Zeissig S, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134: 743-756.
46. Seiderer J, Brand S, Herrmann KA, Schnitzler F, Hatz R, et al. (2006) Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm Bowel Dis 12: 1114-1121.
47. Schnitzler F, Brand S, Staudinger T, Pfennig S, Hofbauer K, et al. (2006) Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease. Immunogenetics 58: 99-106.
48. Stanke F, Becker T, Hedtfeld S, Tamm S, Wienker TF, et al. (2010) Hierarchical fine mapping of the cystic fibrosis modifier locus on 19q13 identifies an association with two elements near the genes CEACAM3 and CEACAM6. Hum Genet 127: 383-394.
49. Bresso F, Askling J, Astegiano M, Demarchi B, Sapone N, et al. (2007) Potential role for the common cystic fibrosis DeltaF508 mutation in Crohn's disease. Inflamm Bowel Dis 13: 531-536.
50. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
51. Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1121.
52. Han SU, Kwak TH, Her KH, Cho YH, Choi C, et al. (2008) CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Oncogene 27: 675-683.
53. Martinez GJ, Zhang Z, Chung Y, Reynolds JM, Lin X, et al. (2009) Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J Biol Chem 284: 35283-35286.
54. Brand S, (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
55. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
56. Abraham C, Cho JH, (2007) Bugging of the intestinal mucosa. N Engl J Med 357: 708-710.